LustGarden Foundation for Pancreatic Cancer Research

Pancreatic Cancer Research

As the largest private funder of pancreatic cancer research, we are relentlessly focused on improving patient outcomes and we are making progress every day. Thanks to separate funding to support administrative expenses, 100 percent of every donation goes directly to research.

Navigating Pancreatic Cancer

We are here to empower you to ask bold questions, seek out the best treatment options, and face the unique challenges of pancreatic cancer head-on. We want to give you the resources and information you need to make informed decisions that are best for you.

Patient Checklist

Checklist

August 1, 2018 ladmin
As overwhelming as a pancreatic cancer diagnosis is, it is important to act quickly and put a treatment plan into place. Treatment should ideally begin within one month after you receive your diagnosis. Understand your disease. Thoroughly understand what stage of pancreatic cancer you have and inquire about having your blood and tumor genetically sequenced. […]
Learn More
Lets Win! Pancreatic Cancer

Let’s Win! Pancreatic Cancer

July 20, 2018 ladmin
LET’S WIN! Pancreatic Cancer A Dynamic Way to Share Information Recognizing that there is an urgent need for patients to communicate amongst themselves and with the medical community about potentially life-changing treatments and clinical trials, we are proud to be affiliated with Let’s Win. Let’s Win is an interactive online community where patients and families […]
Learn More

Pancreatic Cancer Connections

July 7, 2018 ladmin
Pancreatic Cancer Connections is online social community that provides a safe space for pancreatic cancer patients and their loved ones to share their experiences, get valuable coping resources, and support one another. Patients interact with others who are facing a pancreatic cancer and can post questions to the board or message other members privately. This community forum is a valuable resource for patients, caregivers, and their loved ones to refer to at various stages of their treatment and recovery. Patients and loved ones can sign up for Pancreatic Cancer Connections at no cost and will be welcomed into an engaging and supportive community to discuss topics including treatment options, nutrition, and coping with the disease. Pancreatic Cancer Connections is hosted by Inspire, a leading healthcare social network that connects more than 1,000,000 patients and caregivers.
Learn More

Lustgarten News

View All Articles

Meet Our New CEO

The Lustgarten Foundation today announced the appointment of Linda Tantawi as Chief Executive Officer. As CEO, Tantawi will expand the organization’s national presence to achieve its mission of finding a cure for pancreatic cancer. Since 1998, the Lustgarten Foundation has been at the forefront of advancements in understanding the disease and developing new and more effective treatments.

Announcing Tantawi’s appointment, Foundation Chairman Andrew Lustgarten said: “With the incredible vision of the Foundation’s previous leaders, we’ve made important strides—taking pancreatic cancer from an unsupported ‘orphan disease,’ to one that is now supported by a robust research program. Linda’s leadership skills and extensive experience in fundraising for national cancer nonprofits will help take the Foundation, and the research we support, to the next level.”

Learn More

Interview With An Expert

Interview With An Expert Clinical Trials Update

Q&A with Allyson J. Ocean, M.D. Clinical trials are scientific experiments that move medicine forward to help people live longer and live well. Clinical trials are the backbone of advancing medicine, and in some instances, a clinical trial can lead to a cure for a disease. They involve rigorous study and are designed to answer many questions including if a potential treatment is safe, if it works, how it works, if it is more effective than other treatments currently available, if there are any side effects and which patients will benefit most from a particular treatment. Before any new cancer treatment is tested in people, it is studied extensively in the laboratory.

Learn More

New Fellowships Honor Icons of Civil & Gender Rights

PROGRAM INFORMATION Each year, more than 45,000 Americans are lost to pancreatic cancer—parents, grandparents, siblings, children, friends and other beloved members of our communities. And because pancreatic cancer does not discriminate, it also claims the lives of national figures whose loss is felt not only by their immediate family members and friends but by the entire country and even around the world. Unfortunately, 2020 saw the loss of two such figures to pancreatic cancer: Civil Rights icon and 17-term Georgia Congressman John Lewis on Friday, July 17 and Equal Rights champion and longtime U.S. Supreme Court Justice Ruth Bader Ginsburg on Friday, Sept. 18.

Learn More

Pancreatic Cancer News

View All Articles

Molecular imaging scientist recognized as one of the top biomedical engineers in U.S.

23. 2. 21 ladmin
UC Davis professor of biomedical engineering and hematology/oncology Julie Sutcliffe has been elected to the American Institute for Medical and Biological Engineering (AIMBE) College of FellowsJulie Sutcliffe, UC Davis professor of biomedical engineering and hematology/oncology Julie Sutcliffe, UC Davis professor of biomedical engineering and hematology/oncology Sutcliffe was elected by members of the College of Fellows […]
Read More

Drug Developed by Georgia State Researcher Is Promising Against Pancreatic and Breast Cancers Drug Developed by Georgia State Researcher Is Promising Against Pancreatic and Breast Cancers

9. 2. 21 ladmin
ProAgio, a drug developed by Georgia State University biology professor Zhi-Ren Liu and his team, is effective at treating pancreatic cancer and prolonging survival in mice, according to a study published in the journal Cellular and Molecular Gastroenterology and Hepatology. A second study, published in the Journal of Experimental Medicine, shows the drug is also effective against triple-negative breast […]
Read More

CAR T cells targeting the CEACAM7 protein show promise in pancreatic cancer

25. 1. 21 ladmin
CAR T cells modified to recognise CEACAM7 were able to eliminate pancreatic ductal adenocarcinoma cells in a late-stage model without toxic effects on healthy tissue. Researchers have identified and validated a promising protein target that could be used in novel chimeric antigen receptor (CAR) T-cell therapies for pancreatic cancer. According to the team, this is […]
Read More

Scientists unveil a promising new strategy for combating pancreatic cancer

16. 12. 20 ladmin
A DNA mutation that occurs frequently in the development of many pancreatic tumors appears to make these cancers vulnerable to an existing type of drug known as PARP inhibitors, according to a new study from scientists in the Perelman School of Medicine at the University of Pennsylvania. The discovery, published in Science Advances, centers on a […]
Read More

Compound derived from thunder god vine could help pancreatic cancer patients

14. 12. 20 ladmin
The results of a pre-clinical study led by researchers at the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, suggest how a compound derived from the thunder god vine — an herb used in China for centuries to treat joint pain, swelling and fever — is able to kill cancer cells and […]
Read More

Disrupting the Cellular Process That Promotes Pancreatic Cancer’s Deadly Growth

8. 12. 20 ladmin
esearchers say they’ve identified a way to disrupt a process that promotes the growth of pancreatic cancers — one of the most difficult and deadly cancers to treat. The team, led by scientists at Georgetown Lombardi Comprehensive Cancer Center and including investigators from Lawrence Livermore National Laboratories, STCube and Fluidigm, published their findings today in […]
Read More

Nerves keep pancreatic cancer cells from starving

2. 11. 20 ladmin
Pancreatic cancer cells avert starvation by signaling to nerves, which grow into dense tumors and secrete nutrients. This is the finding of a study with experiments in cancer cells, mice, and human tissue samples published online November 2 in Cell. The study addresses pancreatic ductal adenocarcinoma (PDAC), the deadliest cancer of the pancreas with a five-year […]
Read More

State Capitol goes purple Sunday to raise awareness about pancreatic cancer

29. 10. 20 ladmin
South Dakota’s State Capitol turns purple Sunday (Nov. 1) to honor those who have died from, as well as those who have survived, pancreatic cancer. The seventh annual Light the Capitol Purple for Pancreatic Cancer Awareness ceremony starts at 3pm CT in the Capitol Rotunda in Pierre. Organizer John Moisan of Fort Pierre is a […]
Read More

Testing drugs within a tumor may combat pancreatic cancer drug resistance, ‘time machine’ suggests

29. 10. 20 ladmin
Many patients with pancreatic cancer have only about a 10% chance of survival within five years of their diagnosis because they tend to become resistant to chemotherapy, past studies have indicated. A “time machine” that Purdue University engineers designed to observe pancreatic cancer behavior over time suggests a new drug testing approach that could help scientists better […]
Read More

Ongoing Studies Could Modify the Script in Metastatic Pancreatic Cancer

15. 10. 20 ladmin
Clinical trials should not be viewed as a last resort for patients with metastatic pancreatic cancer, explained Allyson Ocean, MD, who added that even frontline standards of care should be considered after exhausting all available study options. “There are plenty of clinical trials available for your patients. Clinical trials should always be the first consideration […]
Read More

Join Us

Get Involved Today

Get inspired and connect with patients, survivors and loved ones who are all on the same journey.

Donate
Back to Top